IBM Micromedex NeoFax Status
Published by Truven Health Analytics Inc. IBM Micromedex NeoFax app is free to subscribers of IBM Micromedex NeoFax
online.
IBM Micromedex NeoFax app is a reliable resource for on-the-go access
to evidence-based drug information to efficiently and safely manage drug therapy
for neonatal patients.
Are you having issues? Select the issue you are having below and provide feedback to IBM Micromedex NeoFax.
problems reported in the last 24 hours
Reported Issues: 0 Comments
No reports yet! Be the first to report an issue.
Common dislikes about IBM Micromedex NeoFax app
- Difficulties with downloading and installing the app
- Backing up device does not restore password and can result in duplicate billing
- Support and billing need improvement
- App fails to work with dark mode
- Account access issues have not been addressed
- Ineptitude of publishing company
- Have to pay again to use app if changing phone or updating app
- App is unusable in dark mode
- Have to constantly re-enter password
- Neofax made unannounced change to access and instructions did not work
Have a Problem with IBM Micromedex NeoFax? Report Issue
Leave a comment:
Common IBM Micromedex NeoFax Problems & Solutions. Troubleshooting Guide
Complete guide to troubleshoot IBM Micromedex NeoFax app on iOS and Android devices. Solve all IBM Micromedex NeoFax app problems, errors, connection issues, installation problems and crashes.
Table of Contents:
Some issues cannot be easily resolved through online tutorials or self help. So we made it easy to get in contact with the support team at Truven Health Analytics Inc., developers of IBM Micromedex NeoFax.
100% Contact Match
Developer: Mobile Micromedex
E-Mail: [email protected]
Website: Visit IBM Micromedex NeoFax Website
73.91% Contact Match
Developer: Mobile Micromedex
E-Mail: [email protected]
Website: Visit Mobile Micromedex Website
IBM Micromedex NeoFax app is a reliable resource for on-the-go access to evidence-based drug information to efficiently and safely manage drug therapy for neonatal patients. IBM Micromedex NeoFax drug information is intended for full-term babies up to 28 days of age (PNA) and preterm babies up to 44 weeks postmenstrual age (GA + PNA). IBM Micromedex NeoFax is a trusted source for neonatal drug dosing, based on the strict editorial policies and practices that have guided IBM Micromedex NeoFax for more than 30 years. Check with your Chief of Pediatrics, Director of Pediatrics, Director of the NICU, Directory of Pharmacy, Chief Medical Officer, Chief Nursing Officer, Medical Librarian, or anyone else at your facility responsible for clinical reference information. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references. If you work at a facility that subscribes to IBM Micromedex NeoFax, free access requires a password. Evidence-based, fully referenced neonatal-specific drug information enables clinicians to make informed treatment decisions. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 60 different neonatal and infant formulas, and human milk fortifiers. Do you work at a facility that subscribes to IBM Micromedex NeoFax? IBM Micromedex NeoFax app is free to subscribers of IBM Micromedex NeoFax online. It allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere. This neonatal-specific app has clinical value for doctors, nurses, and pharmacists. Existing paid customers will continue to have access to the content going forward.
